Reports for SANDOZ CANADA INCORPORATED
Company Name
SANDOZ CANADA INCORPORATED
Totals |
||
Shortage reports |
2266 |
|
| Actual shortage: | 50 (2%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 19 (1%) | |
| Resolved: | 2197 (97%) | |
Discontinuation Reports |
124 |
|
| To be discontinued: | 4 (3%) | |
| Discontinued: | 118 (95%) | |
| Reversed: | 2 (2%) | |
Late reports |
451 (19%) |
|
Overdue reports |
11 (20%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| DIPHENHYDRAMINE HYDROCHLORIDE INJECTION USP | 50MG | LIQUID | Resolved | 2023-05-01 | 2023-09-20 | 191388 |
| DOBUTAMINE INJECTION USP | 12.5MG | LIQUID | Resolved | 2022-09-01 | 2022-10-26 | 168466 |
| DOBUTAMINE INJECTION USP | 12.5MG | LIQUID | Resolved | 2023-04-21 | 2023-07-05 | 190144 |
| DOCETAXEL INJECTION | 10MG | SOLUTION | Resolved | 2017-03-14 | 2017-05-17 | 2556 |
| DOCETAXEL INJECTION | 10MG | SOLUTION | Resolved | 2018-10-15 | 2019-01-16 | 64230 |
| DOCETAXEL INJECTION | 10MG | SOLUTION | Avoided shortage | 2024-01-08 | 2024-02-05 | 215330 |
| DOCETAXEL INJECTION | 10MG | SOLUTION | Avoided shortage | 2025-01-28 | 2025-02-03 | 248843 |
| DOCETAXEL INJECTION | 10MG | SOLUTION | Resolved | 2025-02-03 | 2025-04-25 | 249508 |
| EPHEDRINE SULFATE INJECTION USP | 50MG | LIQUID | Resolved | 2022-03-25 | 2022-03-31 | 157408 |
| ESTALIS 140/50 MCG | 0.62MG 2.7MG | PATCH | Resolved | 2017-03-23 | 2017-06-09 | 4100 |
| ESTALIS 140/50 MCG | 0.62MG 2.7MG | PATCH | Resolved | 2017-06-28 | 2017-10-27 | 14305 |
| ESTALIS 140/50 MCG | 50MCG 140MCG | PATCH | Resolved | 2020-09-08 | 2020-09-23 | 123865 |
| ESTALIS 140/50 MCG | 50MCG 140MCG | PATCH | Resolved | 2020-11-25 | 2021-01-04 | 128877 |
| ESTALIS 140/50 MCG | 140MCG 50MCG | PATCH | Resolved | 2022-08-29 | 2022-09-10 | 168144 |
| ESTALIS 140/50 MCG | 140MCG 50MCG | PATCH | Resolved | 2023-02-14 | 2023-03-03 | 184628 |
| ESTALIS 140/50 MCG | 140MCG 50MCG | PATCH | Resolved | 2023-05-01 | 2023-05-09 | 191385 |
| ESTALIS 140/50 MCG | 140MCG 50MCG | PATCH | Resolved | 2023-10-16 | 2023-11-07 | 207082 |
| ESTALIS 140/50 MCG | 140MCG 50MCG | PATCH | Resolved | 2024-01-23 | 2024-02-19 | 217041 |
| ESTALIS 140/50 MCG | 140MCG 50MCG | PATCH | Resolved | 2024-10-15 | 2024-12-11 | 240297 |
| ESTALIS 140/50 MCG | 140MCG 50MCG | PATCH | Resolved | 2025-03-31 | 2025-08-04 | 253662 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TOBRAMYCIN INHALATION SOLUTION | 300MG | SOLUTION | Discontinued | 2021-09-02 | 2021-09-02 | 145015 |
| VITAMIN B12 | 100MCG | LIQUID | Discontinued | 2017-06-06 | 2017-07-01 | 12133 |
| ZOFRAN ODT | 8MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2022-12-08 | 2023-03-14 | 177540 |
| ZOFRAN ODT | 4MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2023-03-14 | 2023-03-14 | 187062 |